Teriparatide Acetate CAS: 99294-94-7

Short Description:

It is applicable to the treatment of osteoporosis in postmenopausal women with high risk of fracture


Product Detail

Product Tags

Product Detail

Name: Teriparatide Acetate  

Feature: 

Bone metabolism is mediated by inhibiting osteoblast apoptosis, activating bone lining cells and enhancing osteoblast differentiation. The PHT-I receptor on the surface of osteoblasts, bone lining cells and bone marrow stromal stem cells is intermittently stimulated by regulating the adenylate cyclase – cyclic adenosine monophosphate – protein kinase A conduction pathway to promote the differentiation of osteoblasts and prolong the life of osteoblasts; Stimulate the proliferation of osteoblast cell line through phosphate C-cytoplasmic calcium ion-protein kinase C signal chemicalbook signal transduction pathway; By suppressing PPAR γ The trans-activation activity of osteoclast can reduce the differentiation of stromal cells into adipocyte lines and increase the number of osteoblasts; Indirectly regulate bone growth by regulating cytokines, for example, it can induce iGF-1 to combine with osteoblasts, thus promoting bone formation; The process of bone formation is regulated by Wnt signal pathway, thus increasing bone formation.

 

Composition:

Assay: 99%

Appearance: White powder

CAS No. 52232-67-4;99294-94-7

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.


  • Previous:
  • Next:

  • Related Products